Conflict of interest or ideological divide: the need for ongoing collaboration between physicians and industry.

Curr Med Res Opin

Clarus Health, LLC, Roseland, NJ 07068, USA.

Published: September 2006

Continued collaboration between the health profession and industry is essential for future innovation and for fighting disease and illness well into the 21st century. Evidence that suggests conflicts of interest have a negative effect on patient care or the total cost of health care is lacking. Many arguments put forth to address this issue include strictly limiting or severing ties with industry. Research takes place in university, government, and pharmaceutical laboratories, but only industry translates research into drug therapy. While both parties have a shared goal of optimizing health outcomes, industry critics conveniently invoke 'conflict of interest' to express their opinion about the need to more strictly regulate physician/industry interactions. Retreat from industry by academic institutions and working in isolation are simply not strategic options and other points of view must be expressed to help avoid the 'triumph of emotion over fact'.

Download full-text PDF

Source
http://dx.doi.org/10.1185/030079906X120977DOI Listing

Publication Analysis

Top Keywords

industry
6
conflict interest
4
interest ideological
4
ideological divide
4
divide ongoing
4
ongoing collaboration
4
collaboration physicians
4
physicians industry
4
industry continued
4
continued collaboration
4

Similar Publications

IFN-β production induced by PRRSV is affected by GP3 quantity control and CLND4 interaction.

Vet Res

January 2025

Department of Fundamental Veterinary Medicine, College of Veterinary Medicine, Shandong Agricultural University, 61 Daizong Street, Tai'an, 271018, Shandong, China.

Porcine reproductive and respiratory syndrome virus (PRRSV) is one of the most harmful pathogens in the swine industry. Our previous studies demonstrated that the small extracellular domain (ECL2) of CLDN4 effectively blocks PRRSV infection. In this study, we explored the in vivo administration of swine ECL2 (sECL2) and found that it blocked HP-PRRSV infection and alleviated histopathological changes in organs.

View Article and Find Full Text PDF

Background: Drivers of COVID-19 severity are multifactorial and include multidimensional and potentially interacting factors encompassing viral determinants and host-related factors (i.e., demographics, pre-existing conditions and/or genetics), thus complicating the prediction of clinical outcomes for different severe acute respiratory syndrome coronavirus (SARS-CoV-2) variants.

View Article and Find Full Text PDF

The current DSM-oriented diagnostic paradigm has introduced the issue of heterogeneity, as it fails to account for the identification of the neurological processes underlying mental illnesses, which affects the precision of treatment. The Research Domain Criteria (RDoC) framework serves as a recognized approach to addressing this heterogeneity, and several assessment and translation techniques have been proposed. Among these methods, transforming RDoC scores from electronic medical records (EMR) using Natural Language Processing (NLP) has emerged as a suitable technique, demonstrating clinical effectiveness.

View Article and Find Full Text PDF

The Sustainable Development Goals (SDGs) provide a comprehensive framework for societal progress and planetary health. However, it remains unclear whether universal patterns exist in how nations pursue these goals and whether key development areas are being overlooked. Here, we apply the product space methodology, widely used in development economics, to construct an 'SDG space of nations'.

View Article and Find Full Text PDF

Leveraging Model Master Files for Long-Acting Injectables.

Pharm Res

January 2025

Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, , MD, 20993, USA.

The U.S. Food and Drug Administration (FDA) and the Center for Research on Complex Generics (CRCG) hosted a public workshop on May 2-3, 2024, titled "Considerations and Potential Regulatory Applications for a Model Master File (Lachaine et al Can J Psychiatry.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!